Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,857,988
-
Share change
-
-690,094
-
Total reported value
-
$2,817,000
-
Price per share
-
$0.58
-
Number of holders
-
9
-
Value change
-
-$416,405
-
Number of buys
-
2
-
Number of sells
-
9
Institutional Holders of NOVUS THERAPEUTICS INC - COM (NVUS) as of Q4 2019
As of 31 Dec 2019,
NOVUS THERAPEUTICS INC - COM (NVUS) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,857,988 shares.
The largest 9 holders included
ORBIMED ADVISORS LLC, BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, 683 Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, and UBS Group AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.